Marjorie A Underhill

Title: Marjorie A. Underhill: Innovator in Antiviral Compounds

Introduction

Marjorie A. Underhill is a notable inventor based in Pigeon, MI (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral agents. Her work has implications for the treatment of DNA viruses, showcasing her innovative spirit and dedication to advancing medical science.

Latest Patents

Underhill holds a patent for a compound known as 2'-chloropentostatin. This compound is recognized as a potent inhibitor of the enzyme adenosine deaminase. It possesses utility as an agent for enhancing the activity of antiviral agents that target DNA viruses, particularly those containing an adenine moiety, such as 9-(beta-D-arabinosyl)adenine. The patent also details a pure strain of actinomycete, designated ATCC 39365, which is capable of producing 2'-chloropentostatin. Additionally, it outlines a method for producing this compound through aerobic fermentation, along with pharmaceutical compositions that include 2'-chloropentostatin.

Career Highlights

Underhill has worked with Warner-Lambert Company, where she has been able to apply her expertise in pharmaceutical development. Her innovative work has contributed to the advancement of antiviral therapies, making a significant impact in the field.

Collaborations

Throughout her career, Underhill has collaborated with notable colleagues, including John P. Schaumberg and Gerard C. Hokanson. These collaborations have likely enriched her research and contributed to the successful development of her patented compounds.

Conclusion

Marjorie A. Underhill's contributions to the field of antiviral compounds highlight her role as an innovative inventor. Her work continues to influence the development of effective treatments for viral infections.